MRKR MARKER THERAPEUTICS INC Operational Disruptions 8-K Filing 2023 - Announcement Marker Therapeutics, Inc. announced a sustained complete response in the first lymphoma patient treated with MT-601 following CAR T relapse.Get access to all SEC 8-K filings of the MARKER THERAPEUTICS INC